Showing 1 - 20 results of 27 for search 'Mark J. Graham', query time: 0.08s Refine Results
  1. 1
    Bridging Trade-Offs between Traditional and Course-Based Undergraduate Research Experiences by Building Student Communication Skills, Identity, and Interest

    Bridging Trade-Offs between Traditional and Course-Based Undergraduate Research Experiences by Building Student Communication Skills, Identity, and Interest by Alita R. Burmeister, Katie Dickinson, Mark J. Graham

    Published 2021-09-01
    Get full text
    Article
  2. 2
    Classification of Features across Five CURE Networks Reveals Opportunities to Improve Course Design, Instruction, and Equity

    Classification of Features across Five CURE Networks Reveals Opportunities to Improve Course Design, Instruction, and Equity by Alita R. Burmeister, Melanie Bauer, Mark J. Graham

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Recovery from liver disease in a Niemann-Pick type C mouse model

    Recovery from liver disease in a Niemann-Pick type C mouse model by Naomi L. Sayre, Victoria M. Rimkunas, Mark J. Graham, Rosanne M. Crooke, Laura Liscum

    Published 2010-08-01
    Get full text
    Article
  4. 4
    The Need to Be Sure About CUREs: Discovery and Relevance as Critical Elements of CUREs for Nonmajors

    The Need to Be Sure About CUREs: Discovery and Relevance as Critical Elements of CUREs for Nonmajors by Lisa A. Corwin, Erin L. Dolan, Mark J. Graham, David I. Hanauer, Nancy Pelaez

    Published 2018-01-01
    Get full text
    Article
  5. 5
    Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease.

    Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease. by Melanie Vincent, Naomi L Sayre, Mark J Graham, Rosanne M Crooke, David J Shealy, Laura Liscum

    Published 2010-09-01
    Get full text
    Article
  6. 6
    CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation

    CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation by Aaron J Donner, Steve T Yeh, Gene Hung, Mark J Graham, Rosanne M Crooke, Adam E Mullick

    Published 2015-01-01
    Get full text
    Article
  7. 7
    An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

    An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis by Rosanne M. Crooke, Mark J. Graham, Kristina M. Lemonidis, Charles P. Whipple, Seonjoon Koo, Ranjan J. Perera

    Published 2005-05-01
    Get full text
    Article
  8. 8
    Perceived supports and evidence-based teaching in college STEM

    Perceived supports and evidence-based teaching in college STEM by Meghan E. Bathgate, Oriana R. Aragón, Andrew J. Cavanagh, Jonathan K. Waterhouse, Jennifer Frederick, Mark J. Graham

    Published 2019-04-01
    Get full text
    Article
  9. 9
    More frequent utilization of evidence-based teaching practices leads to increasingly positive student outcomes

    More frequent utilization of evidence-based teaching practices leads to increasingly positive student outcomes by Philip M. Reeves, Melanie Bauer, Melanie Bauer, Julia C. Gill, Cong Wang, David I. Hanauer, Mark J. Graham

    Published 2024-04-01
    Get full text
    Article
  10. 10
    Student Reflection Papers on a Global Clinical Experience: A Qualitative Study

    Student Reflection Papers on a Global Clinical Experience: A Qualitative Study by Carmi Z. Margolis, Robert M. Rohrbaugh, Luisa Tsang, Jennifer Fleischer, Mark J. Graham, Anne Kellett, Janet P. Hafler

    Published 2017-06-01
    Get full text
    Article
  11. 11
    Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice

    Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice by Mark J. Graham, Kristina M. Lemonidis, Charles P. Whipple, Amuthakannan Subramaniam, Brett P. Monia, Stanley T. Crooke, Rosanne M. Crooke

    Published 2007-04-01
    Get full text
    Article
  12. 12
    Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice[S]

    Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice[S] by Adam E. Mullick, Wuxia Fu, Mark J. Graham, Richard G. Lee, Donna Witchell, Thomas A. Bell, Charles P. Whipple, Rosanne M. Crooke

    Published 2011-05-01
    Get full text
    Article
  13. 13
    Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp −/− mice

    Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp −/− mice by Elizabeth P. Newberry, Susan M. Kennedy, Yan Xie, Jianyang Luo, Rosanne M. Crooke, Mark J. Graham, Jin Fu, Daniele Piomelli, Nicholas O. Davidson

    Published 2012-04-01
    Get full text
    Article
  14. 14
    Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein

    Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein by Richard G. Lee, Wuxia Fu, Mark J. Graham, Adam E. Mullick, Donna Sipe, Danielle Gattis, Thomas A. Bell, Sheri Booten, Rosanne M. Crooke

    Published 2013-03-01
    Get full text
    Article
  15. 15
    Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response[S]

    Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response[S] by Andrew J. Lutkewitte, Kyle S. McCommis, George G. Schweitzer, Kari T. Chambers, Mark J. Graham, Lingjue Wang, Gary J. Patti, Angela M. Hall, Brian N. Finck

    Published 2019-03-01
    Get full text
    Article
  16. 16
    Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.

    Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development. by Seonwook Kim, Lihua Yang, Seongu Kim, Richard G Lee, Mark J Graham, Judith A Berliner, Aldons J Lusis, Lei Cai, Ryan E Temel, Debra L Rateri, Sangderk Lee

    Published 2017-01-01
    Get full text
    Article
  17. 17
    Benefits of a College STEM Faculty Development Initiative: Instructors Report Increased and Sustained Implementation of Research-Based Instructional Strategies

    Benefits of a College STEM Faculty Development Initiative: Instructors Report Increased and Sustained Implementation of Research-Based Instructional Strategies by Mary F. Durham, Oriana R. Aragón, Meghan E. Bathgate, Aiyana Bobrownicki, Andrew J. Cavanagh, Xinnian Chen, William M. Trochim, Jonathan K. Waterhouse, Mark J. Graham, Brian A. Couch

    Published 2020-01-01
    Get full text
    Article
  18. 18
    The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis

    The lipid droplet-associated protein perilipin 3 facilitates hepatitis C virus-driven hepatic steatosis by Daniel Ferguson, Jun Zhang, Matthew A. Davis, Robert N. Helsley, Lise-Lotte Vedin, Richard G. Lee, Rosanne M. Crooke, Mark J. Graham, Daniela S. Allende, Paolo Parini, J.Mark Brown

    Published 2017-02-01
    Get full text
    Article
  19. 19
    A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans

    A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans by Nicholas R Jones, Melissa A Pegues, Mark A McCrory, Walter Singleton, Claudette Bethune, Brenda F Baker, Daniel A Norris, Rosanne M Crooke, Mark J Graham, Alexander J Szalai

    Published 2012-01-01
    Get full text
    Article
  20. 20
    Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice

    Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice by Rosie Z Yu, Mark J Graham, Noah Post, Stan Riney, Thomas Zanardi, Shannon Hall, Jennifer Burkey, Colby S Shemesh, Thazha P Prakash, Punit P Seth, Eric E Swayze, Richard S Geary, Yanfeng Wang, Scott Henry

    Published 2016-01-01
    Get full text
    Article

Search Tools: